Analysis: Rapid infusion of infliximab safe, possibly beneficial in IBD

07/17/2013 | Healio

Researchers who looked at findings from 10 studies found rapid infusions of infliximab did not raise risks among patients with inflammatory bowel disease and other other conditions, compared with standard infusions. In addition, University of Michigan researchers reported that nine of the studies, seven of which were focused on IBD patients, suggested a reduced reaction risk when comparing rapid and standard infusion.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC